q3 adjusted earnings per share $1.07 excluding items.
qtrly recurring revenues increased 16%.
sees fy 2021 adjusted earnings per share growth of 11% to 15%.
sees fy sales $240 million to $280 million.
qtrly adjusted operating income rose 17% to $177 million.
qtrly recurring revenues rose 16 percent to $751 million.
qtrly organic sales increased 7 percent.
reaffirms full-year 2021 adjusted earnings per share guidance of 11% to 15%.
qtrly net sales $30 million versus refinitiv ibes estimate of $29.5 million.
reaffirms fiscal year 2022 guidance.
qtrly recurring revenues $410 million versus refinitiv ibes estimate of $410.5 million.
sees fy sales $240 million to $280 million.
qtrly event-driven revenues rose to $76 million, driven by higher mutual fund proxies.
qtrly revenue $209 million versus refinitiv ibes estimate of $207.5 million.
q1 recurring revenues rose 16 percent to $751 million.
qtrly organic recurring revenue grew 7%.
